Body weight, gender and response to TNF- blockers in axial spondyloarthritis

Abstract

Data suggest that being female, overweight and mostly obese is associated with a lower rate of success in obtaining response status in axial SpA patients treated with anti-TNF drugs. Body weight could represent a modifiable factor to reach the best outcome in axial SpA patients treated with TNF blockers.

References

Page 1

	Year	Citations
The american college of rheumatology 1990 criteria for the classification of fibromyalgia Frederick Wolfe, H A Smythe, Muhammad B. Yunus, Arthritis & Rheumatism	1990	9.5K
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection Martín Rudwaleit, Désirée van der Heijde, R. B. M. Landewé, Annals of the Rheumatic Diseases	2009	3.5K
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis Joachim Sieper, Martín Rudwaleit, Xenofon Baraliakos, Annals of the Rheumatic Diseases	2009	1.6K
Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group Martín Rudwaleit, Anne Grethe Jurik, Kay‐Geert Hermann, Annals of the Rheumatic Diseases	2009	867
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores Pedro Machado, Robert Landewé, E. Lie, Annals of the Rheumatic Diseases	2010	769
Race and Gender Differences in C-Reactive Protein Levels Amit Khera, Darren K. McGuire, Sabina A. Murphy, Journal of the American College of Cardiology Human PolymorphismBlack WomenInflammatory MarkerGender DifferencesImmune-related Gene Polymorphism	2005	750
Executive Summary Obesity Research Drug SafetyWeight Loss MaintenanceWeight LossPharmacological StudyMedicine	1998	750
ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis Désirée van der Heijde, E. Lie, Tore K Kvien, Annals of the Rheumatic Diseases	2008	619
Journal of Biological Regulators and Homeostatic Agents Andrea Bolognesi Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)	2006	547
Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis Martín Rudwaleit Annals of the Rheumatic Diseases	2004	433

Page 1